Hege Marie Vedeld - Concepedia

Author

Hege Marie Vedeld

Oslo University Hospital

Also Known As

H.M. Vedeld, Hege M. Vedeld, Hege Marie Vedeld, Hege Vedeld

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

Oslo University Hospital University of Oslo Norwegian Cancer Society Imperial College London Institute of Biomedical Science

About

Hege Marie Vedeld is an author at Oslo University Hospital specializing in pathology, medicine, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	360
2	Engineering	1	1	57
3	Public Health	1	1	49
4	Biostatistics	1	1	49
5	Cell Biology	1	1	58

Hege Marie Vedeld

Publications

661

Citations

H-Index

Page 1

	Year	Citations
The novel colorectal cancer biomarkers <i>CDO1, ZSCAN18</i> and <i>ZNF331</i> are frequently methylated across gastrointestinal cancers Hege Marie Vedeld, Kim Andresen, Ina A. Eilertsen, International Journal of Cancer Epigenetic ChangeGeneticsPathologyCancer BiologyEpigenetics	2014	118
Four DNA methylation biomarkers in biliary brush samples accurately identify the presence of cholangiocarcinoma Kim Andresen, Kirsten Muri Boberg, Hege Marie Vedeld, Hepatology	2015	108
Novel target genes and a valid biomarker panel identified for cholangiocarcinoma Kim Andresen, Kirsten Muri Boberg, Hege Marie Vedeld, Epigenetics Histone ModificationsEpigenetic ChangePathologyEpigeneticsTumor Biology	2012	78
Re-assessing ZNF331 as a DNA methylation biomarker for colorectal cancer Hege Marie Vedeld, Arild Nesbakken, Ragnhild A. Lothe, Clinical Epigenetics	2018	71
The recently suggested intestinal cancer stem cell marker<i>DCLK1</i>is an epigenetic biomarker for colorectal cancer Hege Marie Vedeld, Rolf I. Skotheim, Ragnhild A. Lothe, Epigenetics PathologyCancer BiologyEpigeneticsTumor BiologyDclk1 Promoter	2014	58
Contribution of <i><scp>MLH</scp>1</i> constitutional methylation for Lynch syndrome diagnosis in patients with tumor <scp>MLH</scp>1 downregulation Diana Pinto, Carla Pinto, Joana Guerra, Cancer Medicine EngineeringEpigenetic ChangeGeneticsDna MethylationPathology	2018	57
CpG island methylator phenotype identifies high risk patients among microsatellite stable <i>BRAF</i> mutated colorectal cancers Hege Marie Vedeld, Marianne A. Merok, Marine Jeanmougin, International Journal of Cancer GeneticsGenetic EpidemiologyPathologyEpigeneticsBiostatistics	2017	49
Early and accurate detection of cholangiocarcinoma in patients with primary sclerosing cholangitis by methylation markers in bile Hege Marie Vedeld, Marit M. Grimsrud, Kim Andresen, Hepatology	2021	48
Evaluation of commercial kits for isolation and bisulfite conversion of circulating cell-free tumor DNA from blood Stine H. Kresse, Sara Brandt‐Winge, Heidi Pharo, Clinical Epigenetics	2023	26
Experimental factors affecting the robustness of DNA methylation analysis Heidi Pharo, Hilde Honne, Hege Marie Vedeld, Scientific Reports	2016	20

Page 1